OBJECTIVE: To compare costs of function- and pain-centred inpatient treatment in patients with chronic low back pain over 3 years of follow-up. DESIGN: Cost analysis of a randomized controlled trial. PATIENTS: A total of 174 patients with chronic low back pain were randomized to function- or pain-centred inpatient treatment. METHODS: Data on direct and indirect costs were gathered by questionnaires sent to patients, health insurance providers, employers, and the Swiss Disability Insurance Company. RESULTS: There was a non-significant difference in total medical costs after 3 years' follow-up. Total costs were 77,305 Euros in the function-centred inpatient treatment group and 83,085 Euros in the pain-centred inpatient treatment group. Likewise, indirect costs after 3 years from lost work days were non-significantly lower in the function-centred in-patient treatment group (6354 Euros; 95% confidence interval -20,892, 8392) and direct medical costs were non-significantly higher in the function-centred inpatient treatment group (574 Euros; 95% confidence interval -862, 2011). CONCLUSION: The total costs of function-centred and pain-centred inpatient treatment were similar over the whole 3-year follow-up.
RCT Entities:
OBJECTIVE: To compare costs of function- and pain-centred inpatient treatment in patients with chronic low back pain over 3 years of follow-up. DESIGN: Cost analysis of a randomized controlled trial. PATIENTS: A total of 174 patients with chronic low back pain were randomized to function- or pain-centred inpatient treatment. METHODS: Data on direct and indirect costs were gathered by questionnaires sent to patients, health insurance providers, employers, and the Swiss Disability Insurance Company. RESULTS: There was a non-significant difference in total medical costs after 3 years' follow-up. Total costs were 77,305 Euros in the function-centred inpatient treatment group and 83,085 Euros in the pain-centred inpatient treatment group. Likewise, indirect costs after 3 years from lost work days were non-significantly lower in the function-centred in-patient treatment group (6354 Euros; 95% confidence interval -20,892, 8392) and direct medical costs were non-significantly higher in the function-centred inpatient treatment group (574 Euros; 95% confidence interval -862, 2011). CONCLUSION: The total costs of function-centred and pain-centred inpatient treatment were similar over the whole 3-year follow-up.
Authors: Mandy Scheermesser; Stefan Bachmann; Astrid Schämann; Peter Oesch; Jan Kool Journal: BMC Musculoskelet Disord Date: 2012-01-23 Impact factor: 2.362
Authors: Mohammad Sidiq; Wadha Alenazi; Faizan Z Kashoo; Mohammad Qasim; Marisia Paz Lopez; Mehrunnisha Ahmad; Suresh Mani; Mohammad Abu Shaphe; Omaymah Khodairi; Abdulqader Almutairi; Shabir Ahmad Mir Journal: PeerJ Date: 2021-10-12 Impact factor: 2.984
Authors: Ann Meulders; Rini Masuy; Lotte Bamelis; Katleen Bogaerts; Bart Depreitere; Kris De Smedt; Jeroen Ceuppens; Bert Lenaert; Sarah Lonneville; Dieter Peuskens; Johan Van Lerbeirghe; Patrick Van Schaeybroeck; Peter Vorlat; Steefka Zijlstra; Johan W S Vlaeyen Journal: BMC Psychol Date: 2022-02-22